pricing News
Most Popular pricing Story
Biosimilar debate focuses on key lawmaker
Palo Alto Democrat Rep. Anna Eshoo has been a key sponsor of the bill backing 12 years of data exclusivity for biologics, a position dearly loved by the 2,000 biomedical companies in California. But Read more...
Latest Headlines
- December 7, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
